Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-25 KLEMT CHRISTIAN Chief Financial Officer Sale −14,341 $10.70 $153K 152,372
2024-12-10 Kapusta Matthew C CEO, Managing Director Exercise or conversion 10b5-1 +100,000 $14.71 $1.5M 697,915
2024-12-10 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −100,000 $15.03 $1.5M 597,915
2024-12-10 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −100,000 0
2024-12-09 Kapusta Matthew C CEO, Managing Director Sale −3,418 $7.63 $26K 597,915
2024-12-09 KLEMT CHRISTIAN Chief Financial Officer Sale −1,796 $7.55 $14K 166,713
2024-12-08 Kapusta Matthew C CEO, Managing Director Grant or award +10,494 601,333
2024-12-08 KLEMT CHRISTIAN Chief Financial Officer Grant or award +3,672 168,509
2024-06-26 Abi-Saab Walid Chief Medical Officer Sale −1,447 $4.36 $6K 115,253
2024-06-19 Gut Robert Director Grant or award +8,080 52,245
2024-06-19 Gut Robert Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-19 Springhorn Jeremy P. Director Grant or award +8,080 31,836
2024-06-19 Springhorn Jeremy P. Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-19 Meek David D. Director Grant or award +8,080 28,332
2024-06-19 Meek David D. Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-19 Balachandran Madhavan Director Grant or award +8,080 31,839
2024-06-19 Balachandran Madhavan Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-19 Kaye Jack Director Grant or award +8,080 14,581
2024-06-19 Kaye Jack Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-19 POST LEONARD E Director Grant or award +8,080 24,079

Page 10 of 13 · 251 trades